Award

Boothroyd honored for Toxoplasma gondii research

He has won the Alice and C.C. Wang Award in Molecular Parasitology
Anna Tancredi
Dec. 24, 2021

In his lab’s early years, John Boothroyd worked with both the protozoan that causes African sleeping sickness, Trypanosoma brucei, and the parasite that causes toxoplasmosis, Toxoplasma gondii. His team was one of the first to report mRNA trans-splicing and polycistronic transcription in eukaryotes from their trypanosome research. But about a decade later, Boothroyd started to feel that the trypanosome research field was becoming saturated; he wanted to go back to his early interest in intracellular biochemistry, so he focused his research on the less-explored Toxoplasma. Since then, his lab has made great strides in understanding host–parasite interactions.

John Boothroyd

Boothroyd has won the American Society for Biochemistry and Molecular Biology’s 2022 Alice and C.C. Wang Award for his seminal contributions to molecular parasitology both in the laboratory and in the greater community.

After earning his Ph.D. at the University of Edinburgh in 1979, Boothroyd was a scientist at the Wellcome Research Laboratories in the United Kingdom for three years before moving to Stanford University, where he’s worked for almost four decades. He is now a professor of microbiology and immunology and associate vice-provost for graduate education and postdoctoral affairs.

On top of his research contributions, Boothroyd aims to better the lives of students and faculty by altering how we view mentorship in the sciences. “One of my passions is to change the academic culture to recognize that mentoring is a really important and really hard job, and that people can benefit from receiving explicit training,” he said.

Elected to the National Academy of Sciences in 2016, Boothroyd continues his work to create a supportive, inclusive scientific community at a national level.

In his own lab, Boothroyd has a team-oriented approach, saying, “I strongly feel that awards like this are to the team, not me.”

In this strain, virulence varies greatly

Toxoplasma gondii has a diverse range of hosts; it can infect nearly any warm-blooded animal, including humans. An estimated 40 million people in the United States are infected with the parasite. Though many cases are asymptomatic, severe toxoplasmosis can be fatal for pregnant individuals or those with weakened immune systems, so it is crucial to understand how these parasites work. John Boothroyd and his team at Stanford want to understand what makes some strains of Toxoplasma so virulent and how the host immune system and the parasite interact.

In their most recent publication, the team used single-cell transcriptomic analysis to examine how host cell gene expression changes upon infection by Toxoplasma gondii. They compared the transcription of Toxoplasma-infected cells with cells that were injected but not invaded by Toxoplasma. While previous studies only had assessed gene expression days after infection, Boothroyd’s team measured transcription within one to three hours. They found that transcription of host immune and cellular stress response genes increases upon injection of rhoptry effector proteins. Exactly how these effectors are introduced into the host cell is one of the lab’s current focuses.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anna Tancredi

Anna Tancredi received a bachelor's degree in molecular biology from Kenyon College.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.